Conversion Diorder

Disclaimer: This information is intended for educational purposes and should not be considered medical advice. Clinical decisions must always be made by a qualified healthcare professional, taking into account the individual patient's circumstances, clinical judgment, and current medical knowledge. This resource is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Overview

• Definition: Conversion Disorder, now formally known as Functional Neurological Symptom Disorder (FNSD) according to DSM-5, is a mental disorder characterized by neurological symptoms (e.g., paralysis, blindness, seizures, tremor) that are inconsistent with known neurological or medical conditions. The symptoms are not intentionally produced or feigned (as in factitious disorder or malingering), and cause significant distress or impairment in social, occupational, or other important areas of functioning. A key feature is objective clinical evidence of incompatibility between the symptom and recognized neurological or medical conditions.
• Epidemiology:
  • Prevalence: Estimates vary widely depending on the population and diagnostic criteria used. Lifetime prevalence in the general population is estimated to be between 0.005% and 3%. Point prevalence in neurological outpatient clinics can be as high as 3-5%, representing a significant portion of undiagnosed neurological conditions.
  • Demographics:
    • Sex: More common in females than males, with reported ratios ranging from 2:1 to 10:1.
    • Age: Can occur at any age, but most commonly diagnosed in young adulthood (e.g., late teens to early 30s). Children and older adults can also be affected.
    • Socioeconomic Status: Appears to be more common in populations with lower socioeconomic status and lower levels of education, though this may be influenced by access to care and diagnostic biases.
  • Comorbidity: High rates of psychiatric comorbidity, particularly anxiety disorders (e.g., panic disorder, generalized anxiety disorder), depressive disorders, dissociative disorders, and personality disorders.
• Classification: FNSD is classified in the DSM-5 under "Somatic Symptom and Related Disorders."
  • Specifiers: Symptoms are classified by type:
    • With weakness or paralysis
    • With abnormal movement (e.g., tremor, dystonic movement, myoclonus, gait disorder)
    • With swallowing symptoms
    • With speech symptoms (e.g., dysphonia, slurred speech)
    • With attacks or seizures (i.e., psychogenic non-epileptic seizures [PNES])
    • With sensory loss (e.g., anesthesia, paresthesia)
    • With special sensory symptom (e.g., visual, olfactory, auditory disturbance)
    • With mixed symptoms
  • Duration Specifiers:
    • Acute: Symptoms present for less than 6 months.
    • Persistent: Symptoms present for 6 months or more.
  • Psychological Stressor Specifier:
    • With psychological stressor: When a psychological stressor (e.g., recent life event, conflict) is identified.
    • Without psychological stressor: No clear psychological stressor identified.

Pathophysiology

• Mechanism: The exact mechanism is not fully understood, but current models point to a complex interplay of psychological, biological, and social factors (biopsychosocial model), leading to altered brain functioning rather than structural damage. Key theories include:
  • Altered Brain Networks: fMRI studies suggest disrupted functional connectivity in brain regions involved in motor control, sensory processing, emotion regulation, self-agency, and attention. For example, there may be hyperactivation of limbic structures (amygdala, insula) with hypoactivation of prefrontal areas responsible for motor initiation or sensory inhibition.
  • Impaired Self-Agency: A common finding is a reduced sense of agency or ownership over the affected body part or action, where patients report symptoms as "happening to them" rather than being consciously willed.
  • Abnormal Top-Down Processing: Descending inhibitory control over motor or sensory pathways may be dysfunctional, leading to abnormal symptom generation.
  • Predictive Processing Errors: The brain's predictive models of movement or sensation may be disrupted, leading to a mismatch between predicted and actual states, manifesting as symptoms.
  • Role of Stress/Trauma: While not always present, psychological stressors, trauma (especially childhood trauma), and adverse life events are strong predisposing and precipitating factors. The "conversion" aspect refers to the idea that psychological distress is expressed as physical symptoms, though this is a simplification of the neurobiological processes.
• Risk Factors:
  • Psychiatric Comorbidity: High rates of anxiety disorders, depressive disorders, PTSD, dissociative disorders, and personality disorders (especially Cluster B traits).
  • Trauma/Adverse Life Events: History of childhood abuse (physical, sexual, emotional), neglect, or recent significant stressors.
  • Neurological Disease: Prior or co-existing neurological conditions (e.g., migraine, epilepsy, stroke) can be a risk factor, potentially by providing a "template" for symptom expression or increasing vulnerability to functional symptoms.
  • Lower Education/Socioeconomic Status: As noted in epidemiology.
  • Suggestibility: Some studies suggest higher levels of hypnotizability or suggestibility.
  • Poor Coping Mechanisms: Inadequate emotional regulation and stress management skills.
• Protective Factors: Not well-defined, but factors that generally promote mental health and resilience may be protective:
  • Strong social support networks.
  • Effective coping strategies for stress.
  • Absence of psychiatric comorbidities.
  • Early identification and appropriate intervention for psychological distress.

Clinical Presentation

Signs and Symptoms

FNSD symptoms are highly variable but typically involve voluntary motor or sensory functions. They are characterized by positive signs of inconsistency rather than merely the absence of organic findings.

• Cardinal Features:
  • Motor Symptoms:
    • Weakness/Paralysis: Often unilateral, can be hemiparesis or monoplegia. Characterized by "give-way" weakness (initially strong, then suddenly collapses under sustained pressure), variability, and inconsistent findings.
    • Abnormal Movements: Tremor (often entrainable, variable frequency/amplitude, distractible), dystonia (fixed or intermittent postures, often with bizarre features), myoclonus, tics.
    • Gait Disturbances: Astasia-abasia (dramatic, often bizarre, lurching, staggering gait without falling), "dragging" or "skate-like" gait, sudden collapses.
    • Speech Symptoms: Dysphonia (whispering, hoarse voice), aphonia (loss of voice), stuttering, globus sensation.
  • Sensory Symptoms:
    • Anesthesia/Paresthesia: Often sharply demarcated (e.g., "glove-and-stocking" distribution, hemisensory loss) that does not conform to dermatomal or neurological distribution.
    • Vision Loss: Monocular or binocular blindness, tunnel vision, diplopia.
    • Hearing Loss: Unilateral or bilateral.
  • Attacks/Seizures (Psychogenic Non-Epileptic Seizures, PNES):
    • Often prolonged, fluctuating, asynchronous movements (thrashing, head-shaking side-to-side), pelvic thrusting, crying, eyes tightly closed, normal pupillary response, no post-ictal confusion or incontinence (though exceptions exist). Typically occur in the presence of others.
• Early Signs:
  • Often sudden onset of symptoms following a stressor or emotionally charged event.
  • Initial presentation may be vague or fluctuate rapidly.
  • Symptoms may initially be attributed to a physical cause until inconsistent signs emerge.
• Advanced Signs:
  • Symptoms become chronic, fixed, and may be associated with secondary complications (e.g., contractures from prolonged immobility, deconditioning).
  • Increased functional impairment and disability.
  • Development of secondary psychiatric comorbidities or worsening of existing ones.
• Atypical Presentations:
  • Rarely, symptoms can mimic stroke (e.g., acute onset hemiparesis, dysarthria, facial droop) or other severe neurological emergencies.
  • Patients may present with multiple, fluctuating, and seemingly unrelated functional symptoms.

Physical Examination

The physical examination is crucial for identifying positive signs of inconsistency.

• Inspection:
  • Observe the patient's spontaneous movements, gait, posture, and interactions.
  • Note any abnormal movements (tremor, dystonia) and assess their variability, distractibility, and entrainability.
  • For gait disorders, look for astasia-abasia, dramatic falls that don't result in injury, or "dragging" of limbs.
  • For PNES, observe the semiology: asynchronous movements, eyes closed/fluttering, pelvic thrusting, absence of typical tonic-clonic phases, prolonged duration, rapid recovery without post-ictal state.
• Palpation:
  • Assess muscle tone: may be normal or variable, sometimes with "give-way" resistance.
  • Check for tenderness: can be present but non-specific.
• Special Tests:
  • Hoover's Sign (for functional leg weakness): When the patient attempts to flex the paretic leg at the hip, the contralateral leg shows absence of the usual downward counter-pressure. Conversely, when the patient exerts downward pressure with the non-paretic leg, there is a normal involuntary extension (lifting) of the paretic leg at the hip. This suggests intact motor pathways despite subjective weakness.
  • Entrainment (for functional tremor): Ask the patient to tap a rhythm with the unaffected hand. If the functional tremor in the affected hand changes frequency to match the tapping, it's a positive sign of entrainment. Alternatively, distraction (e.g., complex cognitive tasks) may reduce or abolish the tremor.
  • Co-contraction (for functional weakness): Ask the patient to resist an examiner's movement. In functional weakness, there may be simultaneous contraction of both agonist and antagonist muscles, which is inefficient and does not produce effective force.
  • Visual Field Testing (for functional visual loss): On formal perimetry, patients with tunnel vision often show a visual field that remains constant in size regardless of the distance from the eye, which is inconsistent with organic causes where the visual field should expand with distance. Optokinetic nystagmus (OKN) to a moving stripe pattern is often preserved despite reported blindness.
  • Sensory Testing (for functional sensory loss): Sharp, non-anatomical demarcation of sensory loss ("split midline," "glove-and-stocking"). Vibratory sense may be preserved on the forehead when reported lost on a functionally numb limb (Riechert's sign).
  • Pronator Drift: May be present but variable, or absent despite reported weakness.
  • Reflexes: Typically normal.
  • Plantar Responses: Typically flexor (down-going).

Diagnostic Approach

History Taking

• Key Questions:
  • Symptom Onset and Evolution: When did symptoms start? Was there a sudden onset? What were the circumstances surrounding the onset (e.g., stressor, minor injury, emotional event)? How have they progressed?
  • Symptom Variability: Do symptoms fluctuate throughout the day? Are they influenced by attention, distraction, or emotional state?
  • Precipitating/Aggravating Factors: What makes the symptoms worse or better?
  • Impact on Functioning: How do the symptoms affect daily activities, work, social life?
  • Past Medical/Neurological History: Any prior neurological conditions, unexplained symptoms, or functional disorders?
  • Psychiatric History: Any history of anxiety, depression, trauma, dissociative symptoms, or other psychiatric disorders?
  • Coping Mechanisms: How does the patient typically cope with stress or difficult emotions?
  • Medication History: Current and past medications.
  • Patient's Beliefs: What does the patient believe is causing their symptoms? Are they open to a non-organic explanation?
  • Secondary Gains: Are there any potential social, financial, or emotional benefits derived from the symptoms (without implying conscious fabrication)? This is distinct from malingering where symptoms are intentionally produced for external incentives.
• Red Flags:
  • Progressive neurological deficits that fit anatomical pathways.
  • Consistent neurological signs on repeated examination.
  • New symptoms that are unequivocally organic (e.g., new papilledema, pathological reflexes).
  • Symptoms resistant to appropriate multidisciplinary treatment for FNSD, warranting re-evaluation for alternative diagnoses.

Laboratory Tests

There are no specific laboratory tests for FNSD. Tests are used primarily to rule out organic causes. - First-Line: - Complete Blood Count (CBC), Basic Metabolic Panel (BMP), Thyroid Function Tests (TFTs), Vitamin B12, Folate, ESR/CRP, ANA: To screen for common systemic or metabolic causes of neurological symptoms (e.g., anemia, electrolyte imbalance, thyroid dysfunction, autoimmune disease). - Drug Screen: Especially if there's suspicion of substance abuse or drug-induced symptoms. - Confirmatory: None for FNSD itself. Diagnosis relies on positive clinical signs and exclusion of organic disease. - Monitoring: None specific for FNSD. May monitor for associated conditions or treatment side effects.

Imaging

Similar to laboratory tests, imaging is used to exclude organic pathology. - Recommended: - Brain MRI with and without contrast: Standard for ruling out structural brain lesions (e.g., tumors, stroke, multiple sclerosis, inflammatory conditions) that could explain the neurological symptoms. This is often essential to reassure both the clinician and the patient. - EEG (Electroencephalogram): Crucial for differentiating psychogenic non-epileptic seizures (PNES) from epileptic seizures. Video-EEG monitoring is the gold standard for PNES diagnosis, capturing an event and showing normal brain activity during the spell. - Advanced: - Spinal MRI: If spinal cord pathology is suspected (e.g., myelopathy, radiculopathy) as an alternative explanation for weakness or sensory symptoms. - Nerve Conduction Studies (NCS) / Electromyography (EMG): To rule out peripheral neuropathies, myopathies, or neuromuscular junction disorders (e.g., Myasthenia Gravis) in cases of weakness or sensory changes. - Functional MRI (fMRI): Currently a research tool, not for routine clinical diagnosis. It provides insights into the altered brain networks in FNSD. - SPECT/PET Scans: Rarely used in diagnosis of FNSD, may be considered in very complex cases if specific metabolic or perfusion abnormalities are suspected for other conditions.

Management

Management of FNSD is multidisciplinary, focusing on early diagnosis, patient education, psychotherapy, and physical/occupational therapy. The approach should be non-judgmental and empathic.

Acute Management

• Immediate:
  • Safety: Ensure patient safety, especially during PNES episodes (protect from injury, avoid restraint).
  • Reassurance: Initial reassurance that symptoms are real and not imagined, but may be understood differently than organic disease.
  • Avoid Iatrogenic Harm: Do not perform unnecessary or invasive tests once FNSD is suspected, as this can reinforce the belief of a severe organic illness.
• Stabilization:
  • Clear Diagnosis Communication: Communicate the diagnosis clearly, positively, and non-judgmentally. Explain FNSD as a common, real disorder of nervous system functioning, where the "software" (functional networks) rather than "hardware" (structure) is affected. Emphasize reversibility.
  • Engage Patient: Encourage acceptance of the diagnosis as a crucial step towards recovery.
  • Referrals: Initiate prompt referrals to appropriate specialists (neurologist, psychiatrist/psychologist, physical/occupational therapist).
• Emergency:
  • Status Epilepticus vs. Status PNES: Differentiating prolonged PNES from status epilepticus is critical. PNES does not respond to anti-epileptic drugs and can lead to iatrogenic complications if treated as status epilepticus. Video-EEG is ideal, but in its absence, careful clinical observation (e.g., eyes closed, asynchronous movements, lack of post-ictal confusion) can guide management.

Chronic Management

• Pharmacological: No specific medications for FNSD itself. Medications are primarily used to treat comorbid psychiatric conditions or associated symptoms.
  • Antidepressants (SSRIs/SNRIs): For comorbid depression or anxiety disorders (e.g., sertraline 50-200 mg/day, escitalopram 10-20 mg/day, venlafaxine XR 75-225 mg/day). Start low and titrate slowly.
  • Anxiolytics: Benzodiazepines should be used cautiously and for short durations due to dependency risk, but may be considered for acute, severe anxiety (e.g., lorazepam 0.5-1 mg PRN).
  • Pain Management: For chronic pain associated with functional symptoms, standard pain management principles apply (e.g., NSAIDs, gabapentin/pregabalin, tricyclic antidepressants).
• Non-pharmacological: These are the cornerstone of FNSD management.
  • Patient Education: Ongoing, consistent education about FNSD as a real, treatable neurological condition. Use metaphors (e.g., computer software glitch) to help understanding.
  • Psychotherapy:
    • Cognitive Behavioral Therapy (CBT): Focuses on identifying and modifying maladaptive thoughts, feelings, and behaviors related to symptoms. Helps with stress management, emotion regulation, and coping.
    • Psychodynamic Therapy: Explores underlying psychological conflicts, past trauma, and emotional stressors that may contribute to symptom development.
    • Acceptance and Commitment Therapy (ACT): Helps patients accept difficult thoughts/feelings and commit to values-driven actions, despite symptoms.
  • Physical Therapy (PT) / Occupational Therapy (OT): Essential for motor and gait symptoms.
    • Focus on retraining normal movement patterns, rather than compensating for "weakness."
    • Use distraction, sensory feedback, and external cues to bypass faulty internal motor programs.
    • Graded exercise and mobilization to prevent deconditioning and improve functional independence.
    • Specific techniques: Mirror therapy, visual feedback, balance training, gait retraining.
  • Multidisciplinary Rehabilitation: A coordinated approach involving neurology, psychiatry, physical therapy, occupational therapy, and social work offers the best outcomes.
• Monitoring:
  • Symptom Resolution: Track improvement or changes in functional symptoms.
  • Functional Status: Monitor progress in daily activities, work, and social engagement.
  • Psychiatric Comorbidity: Regular assessment and management of co-occurring anxiety, depression, etc.
  • Treatment Adherence: Ensure compliance with therapy recommendations.
  • Re-evaluation: Periodically re-evaluate diagnosis if new, consistent organic signs emerge or if symptoms do not respond to appropriate treatment.

Treatment Algorithms

• First-Line:
  1. Positive Diagnosis & Patient Education: Confirm FNSD diagnosis based on positive signs, exclude organic causes with targeted investigations, and provide clear, empathetic explanation of the diagnosis.
  2. Multidisciplinary Approach: Initiate referrals to specialist psychological therapy (CBT, psychodynamic) and physical/occupational therapy tailored to symptoms.
  3. Address Comorbidity: Manage any co-occurring anxiety, depression, or other psychiatric conditions.
• Second-Line:
  1. Intensive Rehabilitation: If outpatient therapy is insufficient, consider inpatient or day-hospital multidisciplinary rehabilitation programs.
  2. Adjunctive Pharmacotherapy: Optimize pharmacological management for comorbid conditions.
  3. Advanced Psychotherapy: Consider more intensive or specialized psychotherapy approaches if initial therapy is not effective.
• Refractory Cases:
  1. Diagnostic Re-evaluation: Re-assess the diagnosis to ensure no organic cause was missed, especially if symptoms worsen or change in an atypical manner.
  2. Review Treatment Adherence: Address barriers to engaging in therapy.
  3. Consider Different Therapeutic Modalities: Explore alternative psychotherapeutic approaches or specialized FNSD programs.
  4. Pain Management/Palliative Care: For chronic, disabling symptoms, focus may shift to symptom management and improving quality of life, similar to other chronic neurological conditions.

Complications

• Common:
  • Functional Impairment: Significant disability in daily activities, work, and social participation.
  • Chronic Pain: Musculoskeletal pain due to abnormal movement patterns or immobility.
  • Deconditioning/Muscle Atrophy: From prolonged immobility or disuse of affected limbs.
  • Social Isolation: Due to difficulty participating in activities and stigma.
  • Psychiatric Comorbidity: Worsening of existing anxiety, depression, or development of new psychiatric issues.
  • Iatrogenic Harm: Unnecessary investigations, treatments, and delays in appropriate care, potentially reinforcing illness behavior.
• Serious:
  • Injury: Falls, especially in patients with gait disturbances.
  • Misdiagnosis: Delay in diagnosis of an underlying organic condition, though rare when appropriate investigations are done.
  • Suicidal Ideation: Due to chronic distress, disability, and feelings of hopelessness.
• Long-term:
  • Persistent disability and poor quality of life if untreated or treatment is unsuccessful.
  • Dependency on caregivers.
  • Financial burden due to loss of employment and healthcare costs.

Prognosis

• Factors:
  • Symptom Duration: Acute onset (<6 months) often has a better prognosis than chronic symptoms.
  • Psychiatric Comorbidity: Absence of severe comorbidity (e.g., severe personality disorder) is associated with better outcomes.
  • Acceptance of Diagnosis: Patients who accept the diagnosis and engage in treatment tend to have better outcomes.
  • Availability of Multidisciplinary Treatment: Access to specialized FNSD clinics or multidisciplinary rehabilitation is crucial.
  • Presence of a Clear Stressor: Identification of a precipitating stressor may correlate with a better prognosis, though this is not always clear.
  • Symptom Type: Motor symptoms (e.g., paresis, gait disturbance) may have a better prognosis than non-epileptic seizures or sensory symptoms.
• Survival: FNSD itself is not directly life-threatening, but severe functional impairment and associated comorbidities can indirectly affect longevity and quality of life.
• Quality of Life: Can be significantly impaired, often comparable to chronic neurological diseases like Parkinson's disease or multiple sclerosis, especially in chronic or severe cases. With effective treatment, quality of life can improve substantially.

Prevention

• Primary: Focuses on promoting mental health and resilience.
  • Stress Management Education: Teaching effective coping strategies for stress.
  • Early Intervention for Trauma: Addressing childhood trauma and adverse life events.
  • Mental Health Promotion: Reducing stigma around mental health issues and encouraging help-seeking behavior.
• Secondary: Early detection and intervention.
  • Prompt Diagnosis: Early recognition of FNSD by clinicians (neurologists, primary care providers) to avoid unnecessary investigations and inappropriate treatments.
  • Therapeutic Communication: Delivering the diagnosis effectively to prevent iatrogenic harm and encourage treatment engagement.
  • Rapid Referral: Timely referral to specialist FNSD programs, psychotherapy, and physical therapy.
• Tertiary: Preventing complications and improving long-term outcomes.
  • Comprehensive Rehabilitation: Multidisciplinary rehabilitation to mitigate disability and improve function.
  • Ongoing Support: Long-term follow-up and management of comorbidities.
  • Patient Advocacy: Empowering patients to manage their condition and navigate healthcare systems.

Special Populations

• Pediatric:
  • Presentation: Often present with motor symptoms (gait disturbance, weakness) or PNES. Symptoms may be more acute and transient.
  • Prognosis: Generally better prognosis than adults, especially with early intervention.
  • Management: Family-based therapy is crucial. Education of parents and school staff is vital. Focus on return to normal activities as quickly as possible.
• Geriatric:
  • Presentation: Can be challenging due to increased prevalence of comorbid organic diseases, making diagnostic clarity more difficult. Symptoms may be misattributed to aging or other neurological conditions.
  • Risk Factors: Higher rates of physical illness, polypharmacy, and social isolation.
  • Management: Requires careful diagnostic evaluation to exclude organic causes. May need adaptation of physical therapy to account for mobility issues or frailty. Addressing social isolation and cognitive factors is important.
• Pregnancy:
  • Considerations: Symptom onset or exacerbation can occur during pregnancy due to physiological and psychological stressors.
  • Medication: Careful consideration of medication safety during pregnancy if treating comorbid psychiatric conditions. Non-pharmacological approaches are preferred.
• Comorbidities:
  • Pain Disorders: FNSD often co-occurs with chronic pain. Management requires a comprehensive pain program, including pharmacotherapy, physical therapy, and psychological interventions (e.g., CBT for pain).
  • PTSD/Trauma: If FNSD is linked to trauma, trauma-focused therapies (e.g., Eye Movement Desensitization and Reprocessing [EMDR], trauma-focused CBT) are indicated in addition to FNSD-specific therapies.
  • Epilepsy and PNES: Some patients may have both true epilepsy and PNES. This requires careful diagnosis (often with video-EEG) and tailored management for both conditions.

Clinical Pearls

• Diagnostic:
  • "Positive Diagnosis": Don't just rule out organic disease; actively look for positive signs of inconsistency (e.g., Hoover's sign, entrainment, give-way weakness, non-anatomical sensory loss). This provides a basis for explaining the diagnosis.
  • Video-EEG is Gold Standard for PNES: Do not rely solely on history. Always confirm PNES with objective monitoring when possible.
  • Beware of "All in their head": Never communicate that symptoms are imaginary. Frame it as a genuine, common, and treatable problem with brain function, not structure.
  • The "Template" Effect: Patients with pre-existing organic neurological disease are not immune to FNSD; in fact, the prior organic disease can sometimes provide a "template" for the functional symptoms.
• Treatment:
  • Therapeutic Alliance: A strong, empathetic clinician-patient relationship is paramount for successful treatment.
  • Education is Therapy: Effective patient education about FNSD is a therapeutic intervention in itself, helping to destigmatize and empower the patient.
  • Early Intervention: The sooner appropriate multidisciplinary treatment starts, the better the prognosis.
  • Focus on Function: Rehabilitation should focus on restoring normal function and movement patterns, not on symptom suppression alone.
• Pitfalls:
  • Over-investigation: Excessive or repetitive testing after FNSD is strongly suspected reinforces the patient's belief in a serious organic disease,